US Employers Cut Marijuana Testing as Positivity Hits 21% in Random Hair Screens
Updated
Updated · The National Law Review · Jul 14
US Employers Cut Marijuana Testing as Positivity Hits 21% in Random Hair Screens
3 articles · Updated · The National Law Review · Jul 14
Summary
Quest Diagnostics’ 2025 data showed marijuana positivity rising even as employers pull back: urine tests reached 4.4%, hair tests about 15%, and random hair screenings 21%—the highest rate cited.
About half of roughly 1,000 employers surveyed in 2024 no longer test for cannabis pre-hire, largely because screening narrows applicant pools; 44% of those still testing said it hurt recruiting.
Citigroup, Amazon, Home Depot and AutoNation are among companies that have already dropped most pre-hire marijuana testing, while trucking and construction are still expected to keep broader panels and rely more on hair tests.
New York bars most marijuana testing for applicants and workers, at least two dozen states protect some medical marijuana users, and a federal move to reclassify cannabis is still pending rather than settled.
The shift is pushing employers toward role-based policies and on-the-job impairment monitoring instead of blanket pre-employment screening, with national rules increasingly harder to apply across states.
As companies drop pot tests to fill jobs, how will they manage the rising risk of on-the-job impairment?
With federal and state marijuana laws clashing, are American workers facing a new era of workplace legal chaos?
Marijuana Positivity in the U.S. Workforce Hits Record High: How Federal Reclassification and Employer Policies Are Rapidly Evolving (2025-2026)
Overview
Between 2025 and 2026, marijuana use among American workers increased significantly, leading to a major shift in how employers approach drug testing. With marijuana now the main substance of concern and its ongoing presence in the workplace, traditional drug screening methods are being re-evaluated. Employers are moving away from automatically disqualifying candidates for positive marijuana tests, especially outside safety-sensitive roles. Instead, they are reallocating resources to focus on detecting actual impairment during work hours. This reflects a broader trend toward more nuanced and practical workplace drug policies that balance safety with changing societal attitudes.